Chlorodehydromethyltestosterone

Chlorodehydromethyltestosterone

Clinical data
Other names	4-Chlordehydromethyltestosterone; Dehydrochloromethyltestosterone; 4-Chloromethandienone
Pregnancy category	AU: X (High risk)
Routes of administration	By mouth
Drug class	Androgen; anabolic steroid
Legal status
Legal status	BR: Class C5 (Anabolic steroids)[1] UK: Class C US: Schedule III
Pharmacokinetic data
Bioavailability	High
Metabolism	Liver
Elimination half-life	16 hours[citation needed]
Excretion	Urine
Identifiers
IUPAC name 4-Chloro-17α-methylandrosta-1,4-dien-17β-ol-3-one
CAS Number	2446-23-3 N
PubChem CID	98521
ChemSpider	88972 Y
UNII	ZPZ473F40K
CompTox Dashboard (EPA)	DTXSID10179216
ECHA InfoCard	100.392.451
Chemical and physical data
Formula	C20H27ClO2
Molar mass	334.88 g·mol−1
3D model (JSmol)	Interactive image
SMILES O=C1\C=C/[C@]4(/C(=C1/Cl)CC[C@@H]3[C@@H]4CC[C@]2([C@H]3CC[C@@]2(O)C)C)C
InChI InChI=1S/C20H27ClO2/c1-18-9-8-16(22)17(21)15(18)5-4-12-13(18)6-10-19(2)14(12)7-11-20(19,3)23/h8-9,12-14,23H,4-7,10-11H2,1-3H3/t12-,13+,14+,18-,19+,20+/m1/s1 Y Key:AGUNEISBPXQOPA-XMUHMHRVSA-N Y
NY (what is this?)  (verify)

Chlorodehydromethyltestosterone (CDMT; brand name Oral Turinabol), also known as 4-chloro-17β-hydroxy17α-methylandrosta-1,4-dien-3-one, is an anabolic–androgenic steroid (AAS). It is the 4-chloro-substituted derivative of metandienone (dehydromethyltestosterone).

CDMT was the first original product of Jenapharm, an East German pharmaceutical company. It was patented in 1961. The idea of combining the structures of 4-chlorotestosterone (clostebol) and metandienone originated with chemist Albert Stachowiak.^{[citation needed]} At the time, this represented a unique dissociation of anabolic from androgenic effects after oral administration.^{[clarification needed][2]} The product was introduced for clinical use in 1965 and remained in use until 1994, when production was discontinued.^{[citation needed]}

This section needs additional citations for verification. Please help improve this article by adding citations to reliable sources in this section. Unsourced material may be challenged and removed. Find sources: "Chlorodehydromethyltestosterone" – news · newspapers · books · scholar · JSTOR (January 2012) (Learn how and when to remove this message)

CDMT was the key steroid administered to approximately ten thousand East German athletes as part of a secret doping program, known as State Plan Topic 14.25, often without them knowing the nature of the "vitamins" they were forced to take. The program remained in place from about 1968 until the collapse of the German Democratic Republic in 1989. In the 1990s, Franke and Berendonk examined GDR archives to elucidate the expansive scope of this operation, which had resulted in numerous medal wins and world-record performances.^[3]

Following allegations^{[by whom?]} of widespread doping, the International Olympic Committee reanalyzed samples from the Beijing 2008 and London 2012 Olympic Games using the spectrometric method developed by Grigory Rodchenkov in 2011^[4] for detecting long-lasting metabolites of CDMT. Weightlifters and sprinters in particular were found to have used CDMT.

In August 2017, UFC Light Heavyweight Champion Jon Jones tested positive for turinabol following his victory over Daniel Cormier at UFC 214 the month prior.^[5]

Colorado Rockies third baseman Colton Welker tested positive in May 2021 while playing for the Triple-A Albuquerque Isotopes. He was suspended for eighty games.^{[citation needed]}

• Chlorodehydromethylandrostenediol
• Chloromethylandrostenediol